NC COIN Welcomes Dr. Sharlini Sankaran, Dr. Steve Greenbaum to Advisory Council

RESEARCH TRIANGLE PARK, N.C. -- NC COIN (North Carolina Center of Innovation for Nanobiotechnology) is continuing to strengthen its team of industry leaders looking to accelerate ideas, drive business, and establish a culture for growth by welcoming Dr. Sharlini Sankaran and Dr. Steve Greenbaum to the organization’s Advisory Council. The additions come as COIN marks the completion of its popular, informative five-week Start Up and Early Stage Legal Series presented in concert with Shanahan Law Group and the NC Biotechnology Center. “Expanding access to resources and opportunities like the Legal Series while gaining insight from respected professionals such as Drs. Sankaran and Greenbaum helps COIN open the gateway to faster development and commercialization of ideas, develop innovative K-12 community programming, and help drive new growth in North Carolina,” Joe Magno, COIN executive director, said.


Sankaran and Greenbaum join fellow industry, academic, research, and professional services leaders from across the state meeting on a quarterly basis to provide guidance and advisement to the COIN Board of Directors and staff regarding programs and events.

Dr. Sankaran is an experienced leader with public policy, economic development, and data management experience. She is Executive Director of REACH NC, a comprehensive statewide web portal to information on research expertise and capabilities at North Carolina’s universities and research institutions. Dr. Sankaran is an active and dedicated volunteer in K-12 and higher Science and Math education, having been involved in the Durham Women and Math mentoring program; serving as judge in the annual North Carolina FIRST Robotics tournament; and speaking on career development to graduate students and postdocs in the sciences and engineering. 

Dr. Greenbaum runs the Homeland Security Division of BAI, a government services company, leading diverse teams of experienced scientists and engineers planning, monitoring, and ensuring compliance for government-sponsored R&D programs. One of his roles at BAI is to build and maintain related workforce development initiatives including internships, consulting projects, and recruiting engagements with graduate programs in relevant scientific and technical areas.

Other COIN Advisory Council members include Dr. Amanda Elam, Galaxy Diagnostics; Dr. Sandra Merkel DeJames, Novozymes; Neal Fowler, Liquidia Technologies; Jinan Glasgow, Neopatents; Dr. Ginger Rothrock, RTI International; and Preston Linn, Nirvana Sciences.

Running from June through the end of July, the Start Up and Early Stage Legal Series was led by Henry Kopf III of Shanahan Law Group and consisted of informative, hands-on sessions designed for professionals involved in startups as well as established businesses and nonprofit organizations. Topics included Pre-Formation and Formation Issues, Hiring and Doing Business, Protecting Intellectual Property, Fundraising and Exits, and International Business Transactions.

In addition to gaining insights from Kopf -- the holder of four U.S. patents who concentrates his practice in the areas of business litigation, business advisement, constitutional takings, administrative law, and technology law -- attendees learned from guest speakers such as David Swintosky of Dunning Capital, an investment banking and financial consulting services group; John Hollenbach, former CEO & President of Doe & Ingalls Management (which was bought by Thermo Fisher); and General David L. Grange, a 30-year U.S. Army veteran and current president of Osprey Global Solutions.

This is the second time COIN has presented the Start Up and Early Stage Legal Series to provide attendees with a solid baseline of knowledge to enhance and improve their business ventures. Attendees were presented with the tools needed to build a proper foundation for their business to prevent future business problems and minimize damage and distractions such problems can cause in addition to learning how to better prepare to discuss issues with their legal team when required.

COIN connects influential business, technology, and educational professionals; provides forums for sharing information on new discoveries and important trends; and promotes innovative technologies to leverage our collective capacity to build a more vibrant economy. Founding members include Novozymes, Kymanox, Danis, CSC Leasing Company, Duke Energy, the North Carolina Biotechnology Center, Applied DNA Sciences, Triad Growth Partners, Total Facility Solutions, Shanahan Law Group, HP, McDonnell Boehnen Hulbert & Berghoff, Jones Lang LaSalle, Liquidia Technologies, Xanofi, RTI International, BAI and Bayer.

For more information on membership contact Karen Shank, Director of Business Development at karens@ncoin.org.

About NC COIN
The North Carolina Center of Innovation for Nanobiotechnology (NC COIN) was organized to promote the economic development and application of nanobiotechnology and related technologies across the State of North Carolina by promoting innovation and commercialization in the fields of nanobiotechnology and nanomedicine. For information visit www.nccoin.org.